Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus

Lupus

Volumn 23, Issue 10, 2014, Pages 1031-1041

  Doe, K ^a   Nozawa, K ^a   Hiruma, K ^a   Yamada, Y ^a   Matsuki, Y ^a   Nakano, S ^a   Ogasawara, M ^a   Nakano, H ^b   Ikeda, T ^b   Ikegami, T ^b   Fujishiro, M ^b   Kawasaki, M ^b   Ikeda, K ^b,c   Amano, H ^a   Morimoto, S ^b,c   Ogawa, H ^b   Takamori, K ^b   Sekigawa, I ^b,c   Takasaki, Y ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Autoantibody; Autoantigen; Chromatin assembly factor 1; Systemic lupus erythematosus

Indexed keywords

AUTOANTIGEN; CHROMATIN ASSEMBLY FACTOR 1; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 1; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER;

ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; ASEPTIC MENINGITIS; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE CONTROL; DNA REPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METAPHASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STANDARD; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; AUTOIMMUNITY; BLOOD; CASE CONTROL STUDY; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE; METABOLISM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHROMATIN ASSEMBLY FACTOR-1; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MALE; YOUNG ADULT;

EID: 84906718732     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314536245     Document Type: Article

References (55)

1. Takasaki Y Fishwild D Tan EM. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med 1984; 159: 981-992.
2. Ogata K Ogata Y Takasaki Y Tan EM. Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. J Immunol 1987; 139: 2942-2946.
3. Takasaki Y Deng JS Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 1981; 154: 1899-1909.
4. Bravo R Frank R Blundell PA Macdonald-Bravo H. Cyclin PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326: 515-517.
5. Prelich G Kostura M Marshak DR Mathews MB Stillman B. The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 replication in vitro. Nature 1987; 326: 471-475.
6. Nichols AF Sancar A. Purification of PCNA as a nucleotide excision repair protein. Nucl Acids Res 1992; 20: 2441-2446.
7. Shivji KK Kenny MK Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992; 69: 367-374.
8. Shivji MKK Podust VN Hubscher U Wood RD. Nucleotide excision-repair DNA-synthesis by DNA polymerase-epsilon in the presence of PCNA RFC and RPA. Biochemistry 1995; 34: 5011-5017.
9. Chuang LSH Ian HI Koh TW Ng HH Xu GL Li BFL. Human DNA (cytosine-5) methyltransferase PCNA complex as a target for p21 (WAF1). Science 1997; 277: 1996-2000.
10. Shibahara K Stillman B. Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled inheritance of chromatin. Cell 1999; 96: 575-585.
11. Chen IT Smith ML Oconnor PM Fornace AJ. Direct interaction of GADD45 with PCNA and evidence for competitive interaction of GADD45 and P2L (WAF1/CIP1) with PCNA. Oncogene 1995; 11: 1931-1937.
12. Graninger WB Hassfeld W Pesau BB Machold KP Zielinski CC Smolen JS. Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Rheumatol 1991; 18: 1621-1622.
13. Miyachi K Fritzler MJ Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978; 121: 2228-2234.
14. Takasaki Y Kaneda K Matsushita M et al. Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients. Int Immunol 2004; 16: 1295-1304.
15. Kaneda K Takasaki Y Takeuchi K et al. Autoimmune responseto proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connectivetissue diseases. J Rheumatol 2004; 31: 2142-2150.
16. Takasaki Y Ohgaki M Kodama A et al. A sandwich type enzyme-linked immunosorbent assay for proliferating cell nuclear antigen (PCNA)/cyclin using monoclonal antibodies. J Immunol Methods 1990; 132: 227-237.
17. Takasaki Y Kogure T Takeuchi K et al. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. J Immunol 2001; 166: 4780-4787.
18. Kogure T Takasaki Y Takeuchi K et al. Autoimmune responses to proliferating cell nuclear antigen multiprotein complexes involved in cell proliferation are strongly associated with their structure and biologic function in patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2946-2956.
19. Smith S Stillman B. Immunological characterization of chromatin assembly factor-1 a human cell factor required for chromatin assembly during DNA replication in vitro. J Biol Chem 1991; 266: 12041-12047.
20. Krawitz DC Kama T Kaufman PD. Chromatin assembly factor I mutants defective for PCNA binding require Asf1/Hir proteins for silencing. Mol Cell Biol 2002; 22: 614-625.
21. Moggs JG Grandi P Quivy JP et al. A CAF-1-PCNA-mediated chromatin assembly pathway triggered by sensing DNA damage. Mol Cell Biol 2000; 20: 1206-1218.
22. Kaufman PD Kobayashi R Kessler N Stillman B. The p150 and p60 subunits of chromatin assembly factor-1-A molecular link between newly synthesized histones and DNA replication. Cell 1995; 81: 1105-1114.
23. Moggs JG Almouzni G. Chromatin rearrangements during nucleotide excision repair. Biochimie 1999; 81: 45-52.
24. Vitali C Bombardieri S Jonsson R et al. Classification criteria for Sjö gren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
25. Arnett FC Edworthy SM Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
26. Tan EM Cohen AS Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
27. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
28. Alarconsegovia D Cardiel MH. Comparison between 3 diagnostic criteria for mixed connectivetissue disease-study of 593 patients. J Rheumatol 1989; 16: 328-334.
29. Bohan A Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-347.
30. ACR AD Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
31. Nozawa K Ikeda K Satoh M et al. Autoantibody to NA14 is an independent marker primarily for Sjö gren's syndrome. Front Biosci 2009; 14: 3733-3739.
32. Hlinkova V Xing G Bauer J et al. Structures of monomeric dimeric and trimeric PCNA: PCNA-ring assembly and opening. Acta Crystallogr D Biol Crystallogr 2008; 64: 941-949.
33. Tchenio T Casella JF Heidmann T. A truncated form of the human CAF-1 p150 subunit impairs the maintenance of transcriptional gene silencing in mammalian cells. Mol Cell Biol 2001; 21: 1953-1961.
34. Nozawa K Fritzler MJ Ikeda K Takasaki Y Satoh M Chan EKL. Differential anti-Golgi complex autoantibody production following murine lactate dehydrogenase-elevating virus infection. Immunopharmacol Immunotoxicol 2008; 30: 13-25.
35. Oura R Arakaki R Yamada A et al. Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages. J Immunol 2013; 190: 578-585.
36. Deobagkar-Lele M Chacko SK Victor ES et al. Interferon-g-and glucocorticoid-mediated pathways synergizeto enhance death of CD4(+) CD8(+) thymocytes during Salmonella enterica serovar Typhimurium infection. Immunology 2013; 138: 307-321.
37. Xu X Yi H Guo Z et al. Splenic stroma-educated regulatory dendritic cells induce apoptosis of activated CD4 T cells via Fas ligand-enhanced IFN-g and nitric oxide. J Immunol 2012; 188: 1168-1177.
38. Zhang ZG Shibahara K Stillman B. PCNA connects DNA replication to epigenetic inheritance in yeast. Nature 2000; 408: 221-225.
39. Lake P Mitchison NA. Associative control of the immune responseto cell surface antigens. Immunol Commun 1976; 5: 795-805.
40. Svenungsson E Andersson M Brundin L et al. Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis 2001; 60: 372-379.
41. Fragoso-Loyo H Richaud-Patin Y Orozco-Narvaez A et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1242-11250.
42. Lu XY Zhu CQ Qian J Chen XX Ye S Gu YY. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection. Lupus 2010; 19: 689-695.
43. Okamoto H Iikuni N Kamitsuji S Yoshio T Minota S Kamatani N. IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients. Rheumatology 2006; 45: 232-234.
44. Santer DM Yoshio T Minota S Moller T Elkon KB. Potent Induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol 2009; 182: 1192-1201.
45. Harigai M Kawamoto M Hara M Kubota T Kamatani N Miyasaka N. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J Immunol 2008; 181: 2211-2219.
46. Yanaba K Bouaziz JD Matsushita T Tsubata T Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009; 182: 7459-7472.
47. Kuroiwa T Lee EG. Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 1998; 7: 597-603.
48. Carroll JM Crompton T Seery JP Watt FM. Transgenic mice expression IFN-gamma in the epidermis have eczema hair hypopigmentation and hair loss. J Invest Dermatol 1997; 108: 412-422.
49. Seery JP Wang ECY Cattell V Carroll JM Owen MJ Watt FM. A central role for alpha/beta T cells in the pathogenesis of murine lupus. J Immunol 1999; 162: 7241-7248.
50. Schroder K Hertzog PJ Ravasi T Hume DA. Interferon-gamma: An overview of signals mechanisms and functions. J Leukoc Biol 2004; 75: 163-189.
51. Saha B Prasanna SJ Chandrasekar B Nandi D. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 2010; 50: 1-14.
52. Taniguchi T Lamphier MS Tanaka N. IRF-1: Thetranscription factor linking the interferon response and oncogenesis. Biochim Biophys Acta 1997; 1333: M9-7.
53. Tamura T Ishihara M Lamphier MS et al. DNA damageinduced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1. Leukemia 1997; 11(Suppl 3): 439-440.
54. Novelli F Bernabei P Ozmen L et al. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha-and beta-chains of its receptor. J Immunol 1996; 157: 1935-1943.
55. Bernabei P Allione A Rigamonti L et al. Regulation of interferon-gamma receptor (IFN-gamma R) chains: A peculiar way to rulethe life and death of human lymphocytes. Eur Cytokine Netw 2001; 12: 6-14.